Crossmark

EDTA-modified carbapenem inactivation method (eCIM) for detecting IMP Metallo-β-lactamase–producing Pseudomonas aeruginosa: an assessment of increasing EDTA concentrations

Crossref DOI link: https://doi.org/10.1186/s12866-020-01902-8

Published Online: 2020-07-20

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lasko, Maxwell J.

Gill, Christian M.

Asempa, Tomefa E.

Nicolau, David P. https://orcid.org/0000-0002-4148-0165
License Information

Text and Data Mining valid from 2020-07-20

Version of Record valid from 2020-07-20
More Information

Article History

Received: 13 April 2020

Accepted: 14 July 2020

First Online: 20 July 2020

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: DPN served as a consultant, speaker’s bureau member or have received research funding from: Allergan, Bayer, Cepheid, Merck, Melinta, Pfizer, Wockhardt, Shionogi, Tetraphase. MJL, CMG, TEA have no conflicts to disclose.

Document is current

Any future updates will be listed below